O T C
PAOG Targets International Segment Of $5 Billion CBD Nutraceutical Market

  Sandusky, OH, May 13, 2021 –  OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion

PAOG Confirms CBD Nutraceutical Q4 Revenue Plans

  Sandusky, OH, May 11, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021. On Friday, PAOG released a preview of the company’s plan to launch a CBD Nutraceuticals line of products.  PAOG’s CBD

PAOG Releases CBD Nutraceutical 2021 Product Launch Preview Highlighting PURA EVERx Partnership, ALKM Co-Packing and USMJ Distribution

  Sandusky, OH, May 7, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company’s plan to launch a CBD Nutraceuticals line of products.  PAOG’s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.

PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday

  Sandusky, OH, May 5, 2021 – OTC PR WIRE — PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived

PAOG CBD Nutraceuticals To Hit Market This Year

  Sandusky, OH, May 4, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive

PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday

  Sandusky, OH, May 3, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive

PAOG Anticipates Boost To CBD Pharmaceutical Research Initiative From Improving Cannabis Legalization Outlook

  Sandusky, OH, April 28, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG’s ongoing CBD Pharmaceutical Development Program. PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in

PAOG Announces Opportunity To Expand CBD Pharmaceutical Research

  Sandusky, OH, April 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived

PURA Schedules Update To Follow Upcoming Annual RPT Highlighting Increasing Interest In ALKM, Breaking Ground In Farmersville, And PAOG and USMJ Partnerships

Dallas, TX, April 12, 2021 – OTC PR WIRE – Puration, Inc. (OTC Pink: PURA) today announced a management update scheduled April 20th, 2021 to follow the upcoming FY2021 Annual Report coming later this week. The update will highlight PURA’s commitment to striking on an opportunity to increase its ownership in Alkame Holdings, Inc. above

PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021

  Sandusky, OH, April 12, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is

Recent Posts

Recent Posts

Contact Us

All Rights Reserved © 2019